PPNA-40

N/A

Report date: 2025/04/24 17:43:09

Base Information

Drug NamePPNA-40

Drug Alias Namepeptide-conjugated antisense oligonucleotide (PPNA) (Techulon)PPNA-40

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsAcinetobacter Baumannii Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTechulon Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTechulon Inc

Active IndicationsN/A

Inactive IndicationsAcinetobacter Baumannii Infections

Other Information

ATC CodeN/A